🇺🇸 FDA
Patent

US 9409990

Methods of inhibiting tumor growth by antagonizing IL-6 receptor

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9409990 (Methods of inhibiting tumor growth by antagonizing IL-6 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K39/39558